Considerations for Transitioning from Paper to eSource
Switching from paper to eSource in clinical trials enhances data accuracy, reduces errors, and boosts organization, offering more efficient study management.
sites
Improving Patient Centricity and Research Access
A clinical research trial can only be as strong its participant population, but it’s challenging to find eligible patients.
Top 10 Educational Resources of 2021
The year 2021 brought many advancements in the clinical research industry. We’ve pushed for more diversity and inclusion in clinical
Unique Ethical Issues in Phase I Oncology Studies
Phase I oncology trials present distinct ethical challenges, such as participant vulnerability and the risk of therapeutic misconception, requiring careful oversight.
Returning to In-person Work: Sponsor Versus Site Viewpoints
As March 2020 completely disrupted any sense of normalcy, including in the workplace, many were forced to adapt rather quickly.
Effectively Working with a Research Technology Vendor During Implementation
As a research site starts the adoption and implementation process for a new technology, there are several moving parts. Sites
Advarra Trend Report: Analyzing Sites by Organization Type
Since early 2020, clinical research sites – like many industries – experienced profound COVID-19 impacts. Specifically, sites had to maneuver
Maintaining Data & Reporting Integrity with Mobile Health
As the COVID-19 pandemic has forced a shift toward remote modalities, mobile health (mHealth) technologies have been on the rise.
Op-ed: Missing Elements of the Discussion on Decentralized Trials
The discussion on decentralized clinical trials (DCTs) has been brought to the forefront in the wake of the COVID-19 pandemic.
Does This Study Require IBC Review?
Gene therapy research is highly regulated due to associated risks, often leading to confusion among professionals new to its regulatory requirements.
4 Questions to Ask When Evaluating Your Research ROI
Key ROI metrics—like publications, staff impact, and core contributions—provide insight into research value and support institutional growth.
Connecting Patient Centricity and eConsent Together
Patient-centric trial design, combined with eConsent, fosters better communication, comprehension, and retention, ensuring a smoother, more informed journey.